These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22629832)

  • 1. [The role of transcription factor Snail1 in the regulation of hormonal sensitivity of in vitro cultured breast cancer cells].
    Andreeva OE; Shcherbakov AM; Shatskaia VA; Krasil'nikov MA
    Vopr Onkol; 2012; 58(1):71-6. PubMed ID: 22629832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationships between snail1 and estrogen receptor signaling in breast cancer cells.
    Scherbakov AM; Andreeva OE; Shatskaya VA; Krasil'nikov MA
    J Cell Biochem; 2012 Jun; 113(6):2147-55. PubMed ID: 22307688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
    Scherbakov AM; Stefanova LB; Sorokin DV; Semina SE; Berstein LM; Krasil'nikov MA
    Exp Cell Res; 2013 Dec; 319(20):3150-9. PubMed ID: 23973669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of protein kinase PAK1 in the regulation of estrogen-independent growth of breast cancer].
    Avilova EA; Andreeva OE; Shatskaia VA; Krasil'nikov MA
    Biomed Khim; 2014; 60(3):322-31. PubMed ID: 25019394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontal Transfer of Tamoxifen Resistance in MCF-7 Cell Derivates: Proteome Study.
    Semina SE; Scherbakov AM; Kovalev SV; Shevchenko VE; Krasil'nikov MA
    Cancer Invest; 2017 Sep; 35(8):506-518. PubMed ID: 28910558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
    Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
    Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs.
    Semina SE; Scherbakov AM; Vnukova AA; Bagrov DV; Evtushenko EG; Safronova VM; Golovina DA; Lyubchenko LN; Gudkova MV; Krasil'nikov MA
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
    Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
    Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
    Lykkesfeldt AE
    Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells.
    Oida K; Matsuda A; Jung K; Xia Y; Jang H; Amagai Y; Ahn G; Nishikawa S; Ishizaka S; Jensen-Jarolim E; Matsuda H; Tanaka A
    Sci Rep; 2014 Feb; 4():4057. PubMed ID: 24531845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
    Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
    Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.
    Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
    J Cell Biochem; 2011 Mar; 112(3):761-72. PubMed ID: 21328450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.